Clinical Trials · NCT02807363
A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Enteris BioPharma Inc.
- Enrollment
- 35
- Start date
- Aug 2017
- Locations
- 1 site, Canada
- Primary endpoint
- Number of Participants With Adequacy of Suppression of Estradiol (E2) as Assessed by Estradiol Level Below 40 pg/mL